By Jennalynn Fung, PharmD Candidate c/o 2025 Introduction I’m a final year pharmacy student completing my Advanced Pharmacy Practice Rotations. I completed one of my ambulatory care pharmacy rotations at Crow/Northern Cheyenne Hospital in Crow Agency, Montana, which serves Native Americans. I had previously worked as a JRCOSTEP in summer of 2021 at the same…

By: Ameena Qadri PharmD Candidate c/o 2027 Advancements in reproductive technology have considerably enhanced fertility treatments, with in-vitro fertilization (IVF) serving as the primary method for many years. IVF facilitates external fertilization of oocytes, offering a solution to infertility. However, this method has presented limitations due to its inability to produce viable gametes and its…

By: Rebecca Sabzanov, PharmD Candidate c/o 2026 On August 9th, 2024, the Food and Drug Administration (FDA) approved Neffy, the first epinephrine intranasal spray, manufactured by ARS pharmaceuticals, for the treatment of anaphylaxis in adults and pediatric patients who weigh at least 30 kilograms.1 Anaphylaxis is a severe allergic reaction which causes a multitude of…

By: Katelyn Hoosein, PharmD Candidate c/o 2025             Alzheimer’s disease (AD) is a neurodegenerative disorder with symptoms that progressively worsen over time, including memory loss, impairment in judgment and problem solving, language deficit, social disengagement, irritability, agitation, aggression, and psychosis. AD typically occurs in patients 60 years of age and older, but, rarely, patients younger…

Amanda Nakhul, Biomedical Sciences c/o 2027 Reproductive rights, specifically abortion, has been a topic of contention for decades. From being pro-choice or pro-life, to debating the circumstances that permit abortion, various opinions have surfaced. Amid these opinions is one of the most critical issues: access. Contraceptive access can make or break a woman’s choice to…

By: Jennalynn Fung, PharmD candidate c/o 2025 Dr. Hyunah Cho, Ph.D., an Assistant Professor in the Department of Pharmaceutical Sciences, was awarded a $745,000 R16 Sure-First grant from the National Institute of General Medical Sciences (NIGMS). Her research is focused on developing nano-based optical imaging agents as prospective tools for brain imaging. If applied clinically,…